2.46

1.23% 0.03

Stereotaxis Inc (STXS)

Overview News Price History Option Chain Discussions Forecast Stock Split

Stereotaxis Inc stock is traded at $2.46, with a volume of 254.25K. It is up +1.23% in the last 24 hours and up +1.23% over the past month. Stereotaxis, Inc. designs, manufactures, and markets robotic systems and instruments for the treatment of abnormal heart rhythms in the United States and internationally. Its products include Niobe ES robotic magnetic navigation system that enables physicians to complete interventional procedures by providing image guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and Vdrive system, which offers navigation and stability for the diagnostic and therapeutic devices designed to enhance interventional procedures. The company also offers Odyssey solution, a real-time information solution to manage, control, record, and share procedures across networks. In addition, it provides disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters; and CARTO RMT navigation and ablation system, CELSIUS RMT, NAVISTAR RMT, NAVISTAR RMT DS, NAVISTAR RMT THERMOCOOL, and CELSIUS RMT THERMOCOOL irrigated tip diagnostic/ablation steerable tip catheters. Further, the company's disposables and other accessories include V-CAS and V-CAS Deflect catheter advancement systems; and V-loop circular and V-Sono ICE catheter manipulators. The company markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with Osypka AG to design and develop a next-generation magnetic ablation catheter using Stereotaxis' robotic technology. Stereotaxis, Inc. was founded in 1990 and is headquartered in St. Louis, Missouri.

Previous Close:

$2.43

Open:

$2.43

24h Volume:

254.25K

Relative Volume:

0.47

Market Cap:

$229.58M

Revenue:

$25.14M

Net Income/Loss:

$-21.57M

P/E Ratio:

-9.1111

EPS:

-0.27

Net Cash Flow:

$-12.23M

1W Performance:

+5.13%

1M Performance:

+1.23%

6M Performance:

+11.31%

1Y Performance:

-0.40%

1-Day Range:

$2.43

$2.4687

1-Week Range:

$2.36

$2.54

52-Week Range:

$1.54

$3.59

Stereotaxis Inc Stock (STXS) Company Profile

Name

Stereotaxis Inc

Sector

Healthcare (1131)

Industry

Medical Instruments & Supplies (58)

Phone

314-678-6100

Address

4320 Forest Park Avenue, Suite 100, St. Louis, MO

Employee

118

Twitter

@stereotaxis

Next Earnings Date

2025-03-03

Latest SEC Filings

STXS's Discussions on Twitter

Compare STXS with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
STXS Stereotaxis Inc	2.46	226.78M	25.14M	-21.57M	-12.23M	-0.27
ISRG Intuitive Surgical Inc	577.81	204.60B	9.61B	2.77B	2.27B	7.555
BDX Becton Dickinson Co	196.33	55.88B	21.84B	1.68B	2.67B	5.8293
ALC Alcon Inc	80.38	39.38B	10.19B	1.05B	1.38B	2.1044
RMD Resmed Inc	244.76	35.68B	5.26B	1.44B	1.76B	9.7713
MDLN Medline Inc	44.13	34.85B	27.43B	1.27B	1.01B	1.5829

Stereotaxis Inc Stock (STXS) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-16-25	Initiated	Citizens JMP	Mkt Outperform
Jan-10-24	Initiated	ROTH MKM	Buy
Jul-12-22	Initiated	Aegis Capital	Buy
Jun-23-22	Initiated	B. Riley Securities	Buy
Jan-05-22	Initiated	Craig Hallum	Buy
Jan-05-22	Initiated	Loop Capital	Buy
May-26-21	Initiated	Piper Sandler	Overweight
Sep-08-20	Initiated	Northland Capital	Outperform
Apr-09-20	Initiated	Cowen	Outperform
Apr-07-20	Initiated	Lake Street	Buy

View All

Stereotaxis Inc Stock (STXS) Latest News

Dec 23, 2025

The Blend of CEO & Investor Synergy in Stereotaxis - Medical Device and Diagnostic industry

Dec 23, 2025

Dec 20, 2025

How Stereotaxis Inc. stock compares with top peersJuly 2025 Breakouts & Daily Risk Controlled Trade Plans - Улправда

Dec 20, 2025

Dec 19, 2025

Stereotaxis shares drop after Q3 loss widens, GenesisX limited launch underway - MSN

Dec 19, 2025

Will Stereotaxis Inc. stock deliver long term returns2025 Technical Patterns & Momentum Based Trading Ideas - DonanımHaber

Dec 19, 2025

How Stereotaxis Inc. stock valuation compares with sector2025 Risk Factors & Daily Volume Surge Signals - Улправда

Dec 19, 2025

Dec 17, 2025

CEO Moves: Why Stereotaxis Inc. stock is popular among millennialsJuly 2025 Intraday Action & Real-Time Volume Trigger Notifications - moha.gov.vn

Dec 17, 2025

Stereotaxis (NYSEAMERICAN:STXS) Now Covered by Citizens Jmp - Defense World

Dec 17, 2025

Dec 16, 2025

Citizens Jmp Begins Coverage on Stereotaxis (NYSEAMERICAN:STXS) - MarketBeat

Dec 16, 2025

This MYR Group Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Tuesday - Sahm

Dec 16, 2025

Citizens Initiates Coverage of Stereotaxis (STXS) with Market Outperform Recommendation - Nasdaq

Dec 16, 2025

Stereotaxis (STXS): Analyst Initiates Coverage with "Market Outp - GuruFocus

Dec 16, 2025

Citizens initiates Stereotaxis stock with Market Outperform rating on robotic surgery growth - Investing.com India

Dec 16, 2025

Short Squeeze: Why Stereotaxis Inc stock is a strong analyst pickJuly 2025 Retail & AI Enhanced Execution Alerts - moha.gov.vn

Dec 13, 2025

Dec 05, 2025

Why Stereotaxis Inc. stock could be top winner2025 Earnings Impact & Daily Market Momentum Tracking - Newser

Dec 05, 2025

Is Stereotaxis Inc. stock vulnerable to rate hikesWeekly Risk Report & Advanced Swing Trade Entry Plans - Newser

Dec 05, 2025

Published on: 2025-12-05 00:51:23 - Newser

Dec 05, 2025

Dec 04, 2025

Published on: 2025-12-04 13:10:01 - Newser

Dec 04, 2025